Local News: Dubois, WY 

 | 

Sign Up

 | 

Sign In

Advertisment

Sepracor News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Sepracor News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Sepracor News

News on Sepracor continually updated from thousands of sources around the net.

Wednesday Dec 2 | Medical News

Sepracor to present clinical study data on STEDESA at the 2009 AES meeting

Sepracor Inc. today announced that clinical study data for STEDESAa will be presented at the 2009 annual meeting of the American Epilepsy Society in Boston.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Epilepsy, Health, Seizures, Carbamazepine (generic), Tegretol, Medication

Sun Nov 15, 2009

The US Market Blog

2009's Magic Formula Buyouts and Bankruptcies

It should come as little surprise that many stocks that make it into the Magic Formula Investing [MFI] screen are attractive acquisition targets.

Comment?

Related Topix: Economics News, Bankruptcy, 9, Biotech, Medicine, Healthcare Industry, Consulting, Gevity HR

Fri Oct 23, 2009

BioSpace

Sepracor, Inc. Deal Closes, CEO in Line for $11 Million

Japanese pharmaceutical giant Dainippon Sumitomo Pharma Co. has completed its $2.6 billion acquisition of Sepracor Inc., triggering change-in-control provisions at the local drug maker that could deliver roughly $11 million in pay and benefits to CEO Adrian Adams.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Oct 22, 2009

Minyanville

Sex, Drugs, and the Rocky Economy: Drugs

Asked to name the most recession-resistant commodities, most people would place "drugs" in the top spot.

Comment?

Related Topix: Drugs, Medicine, Insomnia, Health, Biotech, SanofiSynthlabo, Ambien, Zolpidem (generic), Medication, Sonata, Zaleplon (generic), Healthcare Industry

Wed Oct 21, 2009

Mass High Tech

Sepracor buyout completed; CEO Adams to receive up to $11M

Japanese pharmaceutical giant Dainippon Sumitomo Pharma Co. has completed its $2.6 billion acquisition of Sepracor Inc., triggering change-in-control provisions at the local drug maker that could deliver roughly $11 million in pay and benefits to CEO Adrian Adams.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

American Chronicle

News and FDA Updates for Sepracor

Pasadena, CA - 10/21/09 - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Pasadena, CA, Financial Markets, Opinion

Tue Oct 20, 2009

Freshnews

Dainippon Sumitomo Pharma Co., Ltd. Completes Acquisition of Sepracor Inc

Submitted by admin on 10/20/2009 @ 1:15 PM Companies mentioned in this article: Sepracor Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marlborough, MA, Investment Banking, Financial Services

Wed Oct 14, 2009

Mass High Tech

Dainippon Sumitomo completes Sepracor tender offer

Dainippon Sumitomo Pharma Co. has completed its previously announced tender offer for Sepracor Inc.'s outstanding shares at $23 cash per share.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marlborough, MA, Robots

Tue Oct 06, 2009

Customer Interaction Solutions

Standard & Poor's Announces Changes to U.S. Indices

S&P will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 Indices after the close of trading on Tuesday, October 13: -- S&P SmallCap 600 constituent Atmos Energy Corp.

Comment?

Related Topix: Atmos Energy, Energy, Biotech, Medicine, Healthcare Industry, Monro Muffler Brake, Automotive Service, Cascade Bancorp, Banking, Financial Services, Frontier Financial, Dallas, TX

Thu Sep 24, 2009

Freshnews

Sepracor Announces Expiration of Hart-Scott-Rodino Waiting Period

Sepracor Inc. today announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended , applicable to the acquisition of Sepracor by Dainippon Sumitomo Pharma Co., Ltd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, US News

Business Wire

Public relations, press release distribution, investor relations, SEC filing

ONTARIO, Calif.-- --i.Tech Dynamic today introduced the i.VoicePRO 901, a Bluetooth headset with dual microphones and advanced noise-filtering software to let users hear and be heard cle... DUBLIN-- --Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Corporate Boards:... DUBLIN-- --Research and Markets has ...

Comment?

Related Topix: Business Wire, Startups, Bluetooth, Rubber-Plastics, Manufacturing, Dow Chemical, Chemicals, Biotech, Medicine, Healthcare Industry, San Francisco Metro

Tue Sep 22, 2009

Boston Globe

Inverness deal, Biogen Idec offer reflect acquisition fever among biotech firms

That appears to be the new mantra for the Massachusetts life sciences industry, where the strengthening economy and rising stock market have sparked a small wave of acquisitions.

Comment?

Related Topix: Biotech, Biogen Idec, Science / Technology, Massachusetts, Medicine, Healthcare Industry, California, California Government

Tue Sep 15, 2009

Http

Contents Of The September 14, 2009 Issue Of The WBJ

WORKING HARD Manufacturers give us their hiring outlook. DEAL DOWNLOAD The WBJ looks at the local impact of Marlborough-based Sepracor being acquired by a Japanese pharmaceutical company.

Comment?

Related Topix: Marlborough, MA, Biotech, Medicine, Healthcare Industry, Westborough, MA, Northborough, MA, Grafton, MA

Sun Sep 13, 2009

Http

What's The Impact Of Sepracor-DSP Deal?

It's not often that a billion-dollar acquisition of a local company is greeted with ease by community officials.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Sep 11, 2009

Personal Injury Law News

Levi & Korsinsky, LLP Announces Class Action Lawsuit Against...

Levi & Korsinsky announces that a class action lawsuit has been filed in Delaware Chancery court challenging the proposed acquisition of Sepracor, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Sep 10, 2009

Globe and Mail

Citi May Benefit From M&A Boom

TheStreet.com AP But "the marginal benefit to even selling something at a much better price today than it was three months ago may not amount of a whole lot of beans" Laurie Kulikowski New York - TheStreet.com Last updated on Thursday, Sep.

Comment?

Related Topix: Baker Hughes, Oil & Gas, Biotech, Medicine, Healthcare Industry, Kraft Foods, Food, Insurance, American International Group

Forbes.com

Mixed Signals Leave Asian Markets Flat

Shares fell in Japan and edged slightly higher in China as investors anxiously awaited unemployment data from the U.S. Economists expect it will be dismal.

Comment?

Related Topix: Financial Services, Investment Services, Banking, Biotech, Medicine, Healthcare Industry, Rio Tinto, Mining, Financial Markets

Tue Sep 08, 2009

Seeking Alpha

Sepracora s Great Value Recognized by Japana s Dainippon Sumitomo

Sepracor shares surged up to 30% higher in early afternoon trading as news broke from the Nikkei of an approximately $2.71 billion offer from Dainippon Sumitomo.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law

Mon Sep 07, 2009

The Biotech Stock Blog

Sepracor's Suitor Is Hard to Understand

Well, I didn't see this one coming. Dainippon Sumitomo has announced that it's buying Sepracor .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Sun Sep 06, 2009

The Biotech Stock Blog

Summer Ends with Biotech Buying Spree

Biotech shoppers made some big bets as the summer drew to a close, capped off by Biogen Idec's bid to acquire all of the outstanding shares of Facet Biotech for $14.50 per share in cash, a 64 percent premium to its closing price the previous day.

Comment?

Related Topix: Investment Banking, Investment Services, First Albany Companies, Financial Services, Biogen, Biotech, Medicine, Healthcare Industry, Manufacturing, Industrial Machines, Scientific Instruments, Danaher

Dubois Jobs

Also on Topix